These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36930112)

  • 41. Comprehensive landscape of the miRNA-regulated prognostic marker LAYN with immune infiltration and stemness in pan-cancer.
    Jiawen W; Jinfu W; Jianyong L; Yaoguang Z; Jianye W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):10989-11011. PubMed ID: 37335337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.
    Feng H; Zhang X; Lai W; Wang J
    Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High Expression of SLC16A1 as a Biomarker to Predict Poor Prognosis of Urological Cancers.
    Zhang L; Song ZS; Wang ZS; Guo YL; Xu CG; Shen H
    Front Oncol; 2021; 11():706883. PubMed ID: 34631536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pan-cancer analysis of the oncogenic role of zinc finger protein 419 in human cancer.
    Zhu W; Feng D; Shi X; Li D; Wei Q; Yang L
    Front Oncol; 2022; 12():1042118. PubMed ID: 36578929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.
    Mao W; Zhou J; Hu J; Zhao K; Fu Z; Wang J; Mao K
    Front Public Health; 2022; 10():969070. PubMed ID: 36051999
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pan-Cancer Transcriptome and Immune Infiltration Analyses Reveal the Oncogenic Role of Far Upstream Element-Binding Protein 1 (FUBP1).
    Wang H; Zhang R; Li E; Yan R; Ma B; Ma Q
    Front Mol Biosci; 2022; 9():794715. PubMed ID: 35274005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe?
    Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
    Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pan-cancer analysis identifies ESM1 as a novel oncogene for esophageal cancer.
    Cui Y; Guo W; Li Y; Shi J; Ma S; Guan F
    Esophagus; 2021 Apr; 18(2):326-338. PubMed ID: 33175267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types.
    Hu A; Wang Y; Tian J; Chen Z; Chen R; Han X; Chen Y; Liu T; Chen Q
    Front Oncol; 2022; 12():947054. PubMed ID: 36505822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive Pan-Cancer Analysis of KIF18A as a Marker for Prognosis and Immunity.
    Liu T; Yang K; Chen J; Qi L; Zhou X; Wang P
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

  • 53. Biological and immunological significance of DLL3 expression in different tumor tissues: a pan-cancer analysis.
    Zhang Y; Shang L; Han J; Shen X; Liu H; Yang J; Shi H
    Aging (Albany NY); 2023 Apr; 15(9):3427-3441. PubMed ID: 37179118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive Pan-Cancer Analysis of GINS2 for Human Tumour Prognosis and as an Immunological Biomarker.
    Meng W; Jiang Z; Zhang X; Cai B; Ma L; Guan Y
    Comput Math Methods Med; 2022; 2022():3119721. PubMed ID: 36466552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comprehensive pan-cancer analysis revealing
    Li X; Wang Y; Li X; Kong L; Díez JJ; Wang H; Zhang D
    Gland Surg; 2024 Jun; 13(6):999-1015. PubMed ID: 39015705
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of Chr9p22.1-p21.3 Deletion in Cancer Development: A Pan-cancer
    Gonçalves PG; Reis RM; Bidinotto LT
    Anticancer Res; 2022 Nov; 42(11):5291-5304. PubMed ID: 36288884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic pan-cancer analysis identifies RBM39 as an immunological and prognostic biomarker.
    Zhang R; Wang W; Zhang N; Chen X; Liu W; Zhang L; Liu N
    J Cell Mol Med; 2022 Sep; 26(18):4859-4871. PubMed ID: 35989423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncogenic role of karyopherin α2 (KPNA2) in human tumors: A pan-cancer analysis.
    Sun Y; Li W; Li X; Zheng H; Qiu Y; Yang H
    Comput Biol Med; 2021 Dec; 139():104955. PubMed ID: 34735944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allograft inflammatory factor 1 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer.
    Liu X; Zhang D; Hu J; Xu S; Xu C; Shen Y
    Aging (Albany NY); 2023 Apr; 15(7):2582-2609. PubMed ID: 37014322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
    Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
    Front Genet; 2022; 13():993438. PubMed ID: 36685895
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.